Zurich Cantonal Bank’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$107K Hold
13,588
﹤0.01% 2405
2026
Q1
$92.3K Buy
+13,588
New +$100K ﹤0.01% 2391
2025
Q4
Sell
-14,553
Closed -$161K 2796
2025
Q3
$169K Sell
14,553
-430
-3% -$5.2K ﹤0.01% 2262
2025
Q2
$185K Sell
14,983
-157
-1% -$1.73K ﹤0.01% 2170
2025
Q1
$93.3K Buy
+15,140
New +$157K ﹤0.01% 2409

Other funds holding CRMD

Zurich Cantonal Bank's CRMD Position: Q2 2026 in Review

Zurich Cantonal Bank held its CorMedix (CRMD) position steady in Q2 2026 at 13,588 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #2405.

Zurich Cantonal Bank first reported a position in CRMD in Q1 2025 and has held it in 5 quarters since. The position peaked at $185K in Q2 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Zurich Cantonal Bank held 13,588 shares of CorMedix worth $107K as of Q2 2026.
  • Zurich Cantonal Bank left its CorMedix share count unchanged in Q2 2026.
  • CorMedix made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2405 holding.
  • Zurich Cantonal Bank first reported a position in CorMedix in Q1 2025 and has held it in 5 quarters since.
  • Zurich Cantonal Bank's CorMedix position peaked at $185K in Q2 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.